CSF proteomics of semorinemab Alzheimer's disease trials identifies cell-type specific signatures.
Saved in:
| Title: | CSF proteomics of semorinemab Alzheimer's disease trials identifies cell-type specific signatures. |
|---|---|
| Authors: | Abdel-Haleem AM; Roche Informatics, F. Hoffmann-La Roche Ltd., Mississauga, ON L5N 5M8, Canada., Casavant E; Department of Translational Medicine, Genentech, Inc., South San Francisco, CA 94080, USA., Toth B; Department of Data and Statistical Sciences, Genentech, Inc., South San Francisco, CA 94080, USA., Teng E; Department of Early Clinical Development-OMNI, Genentech, Inc., South San Francisco, CA 94080, USA., Monteiro C; Department of Early Clinical Development-OMNI, Genentech, Inc., South San Francisco, CA 94080, USA., Pandya NJ; Human Pathobiology & OMNI Reverse Translation, Genentech, Inc., South San Francisco, CA 94080, USA., Glock C; Department of Neuroscience, Genentech, Inc., South San Francisco, CA 94080, USA.; gRED Computational Sciences, Genentech, Inc., South San Francisco, CA 94080, USA., Hoogenraad CC; Department of Neuroscience, Genentech, Inc., South San Francisco, CA 94080, USA., Friedman BA; gRED Computational Sciences, Genentech, Inc., South San Francisco, CA 94080, USA., Yeh FL; Department of Translational Medicine, Genentech, Inc., South San Francisco, CA 94080, USA., Anania VG; Department of Translational Medicine, Genentech, Inc., South San Francisco, CA 94080, USA., Novikova G; gRED Computational Sciences, Genentech, Inc., South San Francisco, CA 94080, USA. |
| Source: | Brain : a journal of neurology [Brain] 2026 Jan 08; Vol. 149 (1), pp. 150-162. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase II |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 0372537 Publication Model: Print Cited Medium: Internet ISSN: 1460-2156 (Electronic) Linking ISSN: 00068950 NLM ISO Abbreviation: Brain Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
